Debra Lyon University of Florida

Debra Lyon

Dean/Chair

delyon@ufl.edu 352-273-6335
  • Gainesville FL UNITED STATES
  • College of Nursing

Debra Lyon’s research focuses on symptom management in women with breast cancer and other chronic illnesses.

Contact More Open options

Biography

Debra Lyon’s research focuses on symptom management in women with breast cancer and other chronic illnesses. Her biobehavioral research also explores genetic and molecular markers of inflammation. She is the Executive Aso dean and Kirbo Endowed chair.

Areas of Expertise

Symptom management in breast cancer
Cancer
Genetics

Media Appearances

Debra Lyon awarded two-year NIH R21 grant

University of Florida Health  online

2020-04-02

University of Florida College of Nursing faculty member Debra Lyon, PhD, RN, FAAN received an award for a National Institute of Nursing Research R21 grant, “Metabolomic signature of PN symptoms in breast cancer over the first year of treatment and survivorship” in March. The R21 grant mechanism is intended to encourage exploratory/developmental research by providing support for the early and conceptual stages of project development. The two year, $434,000 grant is poised to make a novel and significant impact by illuminating potential metabolomics measures that are associated with psychoneurologic symptoms in women with early-stage breast cancer.

View More

ONS Names Debra Lyon as Incoming Oncology Nursing Forum Editor

ONS Voice  online

2019-09-16

Oncology nursing-led research is the engine that drives practice change when caring for patients with cancer. As a standard-bearer of oncology nursing research and a veteran of nursing research publications, Debra Lyon, RN, PhD, FNP-BC, FAAN, will bring a wealth of expertise and experience to the Oncology Nursing Forum (ONF), becoming the research journal’s sixth editor effective January 1, 2020.

View More

Social

Articles

Multidimensional Pain Characteristics in Older Adults with Chronic Venous Leg Ulcers

Advances in Wound Care

Junglyun Kim, et al.

2021-07-23

Pain affects wound healing, treatment and quality of life because it has significant impacts on physical, psychological and social wellbeing. The objective of this study was to describe the multidimensional pain characteristics including the sensory, affective, cognitive and behavioral dimensions of CVLU prior to debridement.

view more

Metabolomics: Impact of Comorbidities and Inflammation on Sickness Behaviors for Individuals with Chronic Wounds

Advances in Wound Care

Junglyun Kim, et al.

2021-05-26

Approximately 6.5 million people in the United States suffer from chronic wounds. The chronic wound population is typically older and is characterized by a number of comorbidities associated with inflammation. In addition to experiencing wound-related pain, individuals with chronic wounds commonly experience multiple concurrent psychoneurological symptoms such as fatigue and depression, which delay wound healing.

view more

Addressing Health Disparities From a Syndemic Perspective.

Oncology Nursing Forum

Debra Lyon

2021-05-01

As we enter the second year of the COVID-19 pandemic, there is much hope about the eventual containment of the virus, leading to some form of a new normalcy. Multiple COVID-19 vaccines have proven to be effective, and the vaccination of individuals in the United States has reached several million per day, with an ever-growing percentage of the population having been vaccinated.

view more

Sleep disturbances and associated factors among breast cancer survivors: A 2-year longitudinal study

ONS 46th Annual Congress

Gee Su Yang, et al.

2021-04-29

Breast cancer survivors (BCS) often report poor sleep quality and staying awake throughout the night as the greatest challenges experienced. Sleep disturbances begin or worsen through treatment trajectories, and BCS continue to report sleep disturbances for as long as 10 years following the cessation of cancer treatment. This study aimed to elucidate characteristics of sleep disturbances and determine potential predictors that affect sleep disturbances in a cohort of BCS for two years post-chemotherapy.

view more

Media

Links

Powered By